Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 360 entries
View as:

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00699972 Org: User:
Start: 04/30/08 End: 10/19/10 Due: 10/19/11

E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Phase: N/A Priority: Normal
NCT ID: NCT00337103 Org: User:
Start: 09/20/06 End: 12/11/17 Due: 12/11/18

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00211276 Org: User:
Start: 03/31/05 End: 02/28/07 Due: 02/28/08

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00334958 Org: User:
Start: 02/13/06 End: 05/20/09 Due: 05/20/10

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00050999 Org: User:
Start: 06/30/95 End: 12/31/06 Due: 12/31/07

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00848549 Org: User:
Start: 10/31/08 End: 11/30/11 Due: 11/30/12

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03443063 Org: User:
Start: 02/07/18 End: 08/24/18 Due: 08/24/19

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Phase: N/A Priority: Normal
NCT ID: NCT01987427 Org: User:
Start: 10/30/13 End: 09/03/14 Due: 09/03/15

Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02350309 Org: User:
Start: 12/13/14 End: 04/21/15 Due: 04/21/16

A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04300569 Org: User:
Start: 07/09/20 End: 09/07/20 Due: 09/07/21

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Phase: N/A Priority: Normal
NCT ID: NCT00566254 Org: User:
Start: 12/31/08 End: 03/31/11 Due: 03/31/12

A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00619099 Org: User:
Start: 05/31/08 End: - Due: -

A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01268150 Org: User:
Start: 02/28/11 End: 08/31/13 Due: 08/31/14

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Phase: N/A Priority: Normal
NCT ID: NCT01630057 Org: User:
Start: 09/30/09 End: 07/31/12 Due: 07/31/13

A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

Phase: N/A Priority: Normal
NCT ID: NCT01433991 Org: User:
Start: 10/13/11 End: 03/01/17 Due: 03/01/18

Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00209521 Org: User:
Start: 06/30/02 End: 07/31/03 Due: 07/31/04

Maintenance Intermittent Therapy for Symptomatic GERD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00165841 Org: User:
Start: 10/31/04 End: 06/30/08 Due: 06/30/09

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT00209599 Org: User:
Start: 02/28/05 End: 03/31/05 Due: 03/31/06

Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00069277 Org: User:
Start: 08/31/03 End: 04/30/05 Due: 04/30/06

A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion

Phase: N/A Priority: Normal
NCT ID: NCT01260142 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00097721 Org: User:
Start: 09/30/04 End: 11/30/06 Due: 11/30/07

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01454934 Org: User:
Start: 12/09/11 End: 05/02/16 Due: 05/02/17

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02249078 Org: User:
Start: 12/31/14 End: 04/30/16 Due: 04/30/17

Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

Phase: N/A Priority: Normal
NCT ID: NCT00911534 Org: User:
Start: 01/31/09 End: 10/31/09 Due: 10/31/10

Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT01405053 Org: User:
Start: 06/16/11 End: 11/02/15 Due: 11/02/16